The Milner Therapeutics Institute will form part of a University Enterprise Zone, created through a new government initiative announced today by Universities Minister Chris Skidmore.

Research England, part of UK Research and Innovation, today announced 20 new University Enterprise Zones (UEZs) aimed at helping universities stimulate growth in their local economies, providing vital support for innovative new companies and creating jobs in emerging industries. The £20 million investment will strengthen collaborative ties between universities and businesses.

Cambridge’s UEZ, Greater Cambridge Health Tech Connect, will look at testing and integrating inter-disciplinary models of incubation across West Cambridge, where many of the University’s physical sciences and engineering departments, including its Institute for Manufacturing, are based, and the Cambridge Biomedical Campus in the South. It will address real world challenges, including unmet medical needs, using innovative thinking across disciplines.

“Our aim is to create new ways of collaborating across physics, technology, engineering, biology and medicine and use this to drive innovation in healthcare, manufacturing and engineering,” explains Dr Kathryn Chapman, Deputy Director at the Milner Therapeutics Institute.

“This Enterprise Zone will explore and scale up new and existing models of business incubation, strengthening the interdisciplinary bridge between two major Cambridge research hubs. This will drive new research and development, and deliver a model that can be applied more widely to support company incubation.”

The announcement has been welcomed by Professor Andy Neely, Pro-Vice Chancellor for Enterprise and Business Relations at the University of Cambridge, who led the application. “Cambridge has a rich history of scientific discovery and innovation, and its innovation ecosystem is recognised as world leading. This new government funding will help us build and strengthen connections across often very different disciplines, further accelerating innovation across the city and beyond.”

Read more

 

MILNER THERAPEUTICS SYMPOSIUM

X